Neutrophil activation by anti-proteinase 3 antibodies in wegener's granulomatosis: Role of exogenous arachidonic acid and leukotriene B-4 generation

被引:69
作者
Grimminger, F [1 ]
Hattar, K [1 ]
Papavassilis, C [1 ]
Temmesfeld, B [1 ]
Csernok, E [1 ]
Gross, WL [1 ]
Seeger, W [1 ]
Sibelius, U [1 ]
机构
[1] UNIV LUBECK,DEPT RHEUMATOL,D-23538 LUBECK,GERMANY
关键词
D O I
10.1084/jem.184.4.1567
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among the anti-neutrophil cytoplasmic antibodies (ANCA), those targeting proteinase 3 (PR3) have a high specificity for Wegener's granulomatosis (WG). It is known that a preceding priming of neutrophils with cytokines is a prerequisite for membrane surface expression of PR3, which is then accessible to autoantibody binding. Employing a monoclonal antibody directed against human PR3 and ANCA-positive serum from WG patients with specificity for PR3, we now investigated the role of free arachidonic acid (AA) in autoantibody-related human neutrophil activation. Priming of neutrophils with tumor necrosis factor (TNF-alpha) for 15 min or exposure to anti-PR3 antibodies or incubation with free AA (10 mu M) as sole events did not provoke superoxide generation, elastase secretion or generation of 5-lipoxygenase products of AA. Similarly, the combination of TNF-alpha-priming and AA incubation was ineffective. When TNF-alpha-primed neutrophils were stimulated by anti-PR3 antibodies, superoxide and elastase secretion was provoked in the absence of lipid mediator generation. However, when free AA was additionally provided, a strong activation of the 5-lipoxygenase pathway was demasked, with the appearance of excessive quantities of leukotriene (LT)B-4, LTA(4), and 5-hydroxyeicosatetraenoic acid. Moreover, superoxide and elastase secretion were markedly amplified, and studies with 5-lipoxygenase inhibitors and a LTB(4)-antagonist demonstrated this was due to an LTB(4)-related autocrine loop of cell activation. In contrast, the increased synthesis of platelet-activating factor in response to TNF-alpha-priming and anti-PRS stimulation did not contribute to the amplification loop of neutrophil activation under the given conditions. We conclude that anti-PR3 antibodies are potent inductors of the 5-lipoxygenase pathway in primed human neutrophils, and extracellular free AA as provided at an inflammatory focus, synergizes with the autoantibodies to evoke full-blown lipid mediator generation, granule secretion and respiratory burst. Such events may be enrolled in the pathogenesis of focal necrotizing vascular injury in Wegener's granulomatosis.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 37 条
[1]   BOTULINUM-C2 TOXIN ADP-RIBOSYLATES ACTIN [J].
AKTORIES, K ;
BARMANN, M ;
OHISHI, I ;
TSUYAMA, S ;
JAKOBS, KH ;
HABERMANN, E .
NATURE, 1986, 322 (6077) :390-392
[2]   ANTIBODIES AGAINST GRANULE PROTEINS ACTIVATE NEUTROPHILS INVITRO [J].
CHARLES, LA ;
CALDAS, MLR ;
FALK, RJ ;
TERRELL, RS ;
JENNETTE, JC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (06) :539-546
[3]  
CHILTON FH, 1988, J BIOL CHEM, V263, P5260
[4]   HUMAN-ENDOTHELIAL CELLS STIMULATE LEUKOTRIENE SYNTHESIS AND CONVERT GRANULOCYTE RELEASED LEUKOTRIENE-A4 INTO LEUKOTRIENE-B4, LEUKOTRIENE-C4, LEUKOTRIENE-D4 AND LEUKOTRIENE-E4 [J].
CLAESSON, HE ;
HAEGGSTROM, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 173 (01) :93-100
[5]  
CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244
[6]  
CSERNOK E, 1990, AM J PATHOL, V137, P1113
[7]   THE PATHOGENIC ROLE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES [J].
EWERT, BH ;
JENNETTE, JC ;
FALK, RJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (02) :188-195
[8]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES INDUCE NEUTROPHILS TO DEGRANULATE AND PRODUCE OXYGEN RADICALS INVITRO [J].
FALK, RJ ;
TERRELL, RS ;
CHARLES, LA ;
JENNETTE, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4115-4119
[9]   ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH SPECIFICITY FOR MYELOPEROXIDASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND IDIOPATHIC NECROTIZING AND CRESCENTIC GLOMERULONEPHRITIS [J].
FALK, RJ ;
JENNETTE, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1651-1657
[10]  
FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466